Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Evidence linking HHV-6 with multiple sclerosis: an update.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring.
Pediatric Multiple Sclerosis-A Challenging Demyelinating Disease: Case Report and Brief Review of the Literature.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study.
The diagnosis of multiple sclerosis.
A Combined Inspiratory and Expiratory Muscle Training Program Improves Respiratory Muscle Strength and Fatigue in Multiple Sclerosis.
B lymphocytes in neuromyelitis optica.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Pages
« first
‹ previous
…
283
284
285
286
287
288
289
290
291
…
next ›
last »